Clinical trials
Observational Hyperinsulinism trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2014 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insel Gruppe AG, University Hospital Bern | 1 |
| Prof. Valérie Mc Lin | 1 |
| University Hospital, Basel, Switzerland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperinsulinism | 3 |
| Hypoglycemia | 2 |
| Insulin Resistance | 2 |
| Congenital Portosystemic Shunt | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Genetic Predisposition to Disease | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatopulmonary Syndrome | 1 |
| Hyperammonemia | 1 |
| Hyperandrogenism | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.